Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma.
Francesca M PonziniChristopher W SchultzBenjamin E LeibyShawnna CannadayT YeoJames PoseyWilbur B BowneCharles YeoJonathan R BrodyHarish LavuAvinoam NevlerPublished in: BMJ open (2023)
ClinicalTrials.gov: NCT05055323.